Exhibit (a)(1)(iii)
ALIGOS THERAPEUTICS, INC.
TERMS OF ELECTION
BY PARTICIPATING, YOU AGREE TO ALL TERMS OF THE OFFER AS SET FORTH IN THE OFFER TO EXCHANGE CERTAIN OUTSTANDING OPTIONS TO PURCHASE COMMON STOCK FOR A NUMBER OF REPLACEMENT OPTIONS, DATED JANUARY 30, 2024 (AS IT MAY BE AMENDED FROM TIME TO TIME, THE “OFFER TO EXCHANGE”).
If you would like to participate in this Offer, please indicate your election by making the applicable selections on the option exchange program website at www.myoptionexchange.com by 11:59 P.M. Eastern Time on February 27, 2024 (unless the Offer is extended).
You may withdraw this election by submitting a new properly completed election via the option exchange program website on or prior to the Offer expiration date, which will be 11:59 P.M. Eastern Time on February 27, 2024, unless we extend the Offer.
By electing to exchange your eligible options, you understand and agree to all of the following:
1. I hereby agree to (i) accept the grant by Aligos of my eligible options indicated on my election, to the extent not previously accepted and (ii) exchange my eligible options indicated on my election for replacement options as determined in accordance with the Offer to Exchange on the terms of the Offer as set forth in the Offer to Exchange of which I hereby acknowledge receipt. Each eligible option indicated on my election will be cancelled, on a grant-by-grant basis, following the expiration of the Offer on February 27, 2024, or, if the Offer is extended, on the extended Offer expiration date. Any replacement options will be granted to me on the replacement option grant date, which will be February 28, 2024, in accordance with the terms of the Offer or, if the Offer is extended, on the expiration date of the extended Offer.
2. The Offer is currently set to expire at 11:59 P.M. Eastern Time on February 27, 2024, unless Aligos, in its discretion, extends the period of time during which the Offer will remain open.
3. If I cease to be a resident of the United States or Switzerland or an active employee of Aligos or its subsidiaries or a director of Aligos before the replacement option grant date, I will not receive any new replacement options. Instead, I will keep my current eligible options and they can be exercised or will expire in accordance with their terms.
4. Until 11:59 P.M. Eastern Time on February 27, 2024, or if the Offer is extended, the extended Offer expiration date, I will have the right to withdraw or change the election that I have made with respect to all of my eligible options. HOWEVER, AFTER THAT TIME I WILL HAVE NO ABILITY TO CHANGE MY ELECTION. The last properly submitted election received by Aligos prior to the expiration of the Offer shall be binding. Until the Offer period closes at 11:59 P.M. Eastern Time on February 27, 2024, or if the Offer is extended, the extended Offer expiration date, I may withdraw my tendered eligible options at any time.
5. The tender of my eligible options will constitute my acceptance of all of the terms and conditions of the Offer. Acceptance by Aligos of my eligible options pursuant to the Offer will constitute a binding agreement between Aligos and me upon the terms and subject to the conditions of the Offer.
6. I am the registered holder of the eligible options tendered hereby, and my name and other information appearing on the election are true and correct.
7. I am not required to tender some or all of my eligible options pursuant to the Offer.